What You Should Know:
- FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and existing investors Andera Partners, Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, NEA (New Enterprise
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Abbott Launches Clinical Trial to Optimize Heart Failure Treatment with AI-Powered Monitoring
What You Should Know:
- Abbott, a global healthcare leader, has announced a new clinical trial, TEAM-HF, designed to improve outcomes for patients with worsening heart failure.
- The first-of-its-kind trial will leverage AI and Abbott's CardioMEMS™ HF System to identify patients who may benefit from earlier intervention with advanced therapies, such as a HeartMate 3™ left ventricular assist device (LVAD).
Addressing the Challenges of Advanced Heart Failure
Heart
Read More
Medicare Approves Cleerly’s AI-Powered Heart Scan for Millions of Beneficiaries
What You Should Know:
- In a significant step towards improving cardiovascular care, several Medicare Administrative Contractors (MACs) have granted coverage for Cleerly's AI-enabled Quantitative Coronary Topography (AI-QCT) scans.
- The decision expands access to Cleerly's potentially life-saving technology for Medicare beneficiaries at risk of heart attacks.
Expanding Access to Innovative Cardiac Care
Cleerly, a company dedicated to eradicating heart attacks, sought MAC
Read More
Amwell Integrates with Hello Heart to Offer Digital Cardiovascular Solution
What You Should Know:
- Amwell, a digital health platform, has joined forces with Hello Heart, a pioneer in preventive heart health, to offer a comprehensive digital solution for individuals at risk of cardiovascular disease.
The partnership integrates Hello Heart's innovative program into Amwell's Converge platform, providing a seamless and accessible way for health plan members to manage their heart health.
Addressing a Critical Need
Heart disease remains the leading
Read More
WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA-Cleared 6-Lead ECG Device
What You Should Know:
- WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.
- The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.
Tackling the
Read More
Cedars Sinai Researchers Uses AI to Analyze Regular Chest CT Scans to Predict Heart Disease Risk
What You Should Know:
- Researchers at Cedars-Sinai have developed a new method using artificial intelligence (AI) to assess cardiovascular disease risk during a routine chest computed tomography (CT) scan without contrast dye.
- The recent study published in Nature Communications, could significantly reduce the cost and invasiveness of identifying patients at risk for heart disease.
Leveraging Existing Data for Better Risk Assessment
Traditionally, CT scans with contrast
Read More
Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound device. With affordable, AI-powered medical imaging in a pocket-sized device, caregivers can get to answers immediately to accelerate diagnosis and create new care pathways for heart failure patients at the point of care. As
Read More
Heart Disease: Still the Silent Killer Despite Prevention Options
Given the attention paid to the devastating impact of COVID-19, one might assume it was the leading cause of death in the US. But while the fatalities were stark – almost 1.2 million Americans died of COVID in the last 4 years – heart disease remains the largest cause of death and by a landslide. In 2021, the year with the most COVID-19 deaths (416,893), heart disease claimed 60% more lives (695,000) in the US. Perhaps more, striking, however, is that many, if most, of these deaths, were
Read More
Ventricle Health Secures $8M to Accelerate Value-Based Home Care Model for Heart Failure
What You Should Know:
- Ventricle Health - a new national, virtual cardiology clinical reimagining cardiac care delivery - raises $8M in seed funding led by RA Capital and Waterline Ventures.
- This company will used the seed funding to expand Ventricle Health’s heart failure management therapeutic model in collaboration with value-based care provider groups and payers, which can reduce the overall average annual cost of heart failure care by at least 30-50%.
Virtual
Read More
iRhythm Launches Wearable ECG Heart Monitor
What You Should Know:
iRhythm Technologies, Inc. today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous monitoring (LTCM) service.Zio monitor is iRhythm’s smallest, lightest and thinnest cardiac monitor, enhancing the cardiac monitoring experience for patients and healthcare providers together with new service enhancements. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service.
Read More
